Further easing of import restrictions by the UK Government will provide faster access to patients prescribed cannabis-based medicines — removing yet another barrier in a market expected to grow in the coming years. The use of legal cannabis-based products for medicinal use in humans (CBPMs) is expected to be worth £2.3bn by 2024.
In the UK and Western Europe, there is a high level of concern about the ethics of trade in human tissue, so brokers find it much easier to source samples in other parts of the world. Read the comment from Robert Hewitt, founder of Biosample Hub
This new breed of data-driven service engineer will be able to identify and fix potential problems with machinery before they cause an issue on the line, and, potentially, before a manufacturer even realises there is a problem. Read the comment from Eddie Storan, Head of Global Service, Domino Printing Sciences.